Integrating Single-cell RNA-seq to construct a Neutrophil prognostic model for predicting immune responses in cervical carcinoma

Author:

Qian Hengjun1,Xieyidai Abuduhailili2,Han Songtao3,LV Xiang4,Deng Yuqin5,Feng Yangchun2,Wang Ruozheng6

Affiliation:

1. Yibin Second People's Hospital

2. Cancer Hospital Affiliated to Xinjiang Medical University

3. Affiliated to Traditional Chinese Medicine Hospital of Xinjiang Medical University

4. Provincial Hospital of Fujian Medical University

5. Jianyang People’s Hospital

6. Xinjiang Medical University

Abstract

Abstract Objective: The objective of this study is to comprehensively investigate the communication network within the tumor immune microenvironment (Tumor Immune Microenvironment, TIME) of cervical carcinoma (CC). This involves elucidating the intricate relationships among cells to gain a profound understanding of the interactions between immune cells and tumor cells,as well as the assessment of neutrophil differentiation characteristics and the selection of prognostic genes, the primary goal is to establish a risk model with the ability to predict patients' immune responses and prognosis. Additionally, this model seeks to uncover innovative diagnostic and therapeutic targets for cervical carcinoma, thereby furnishing clinicians with dependable strategies for treatment. Methods: Using single-cell RNA sequencing data (scRNA-seq) obtained from CC samples (E-MTAB-11948), this study employed the Seurat(4.3.0) package to integrate data, remove batch effects, and annotate cell types. A cell communication network was constructed using the iTAKL(0.1.0) package for the analysis of intercellular communication. Neutrophil subpopulations were analyzed utilizing the Monocle2(2.26.0) package to discern various cellular states and conduct pathway analysis using KEGG/GO annotations. Results: we successfully distinguished and further categorized 32 cell populations into 9 major cell types, encompassing T cells, B cells, Mast cells, Neutrophils, Epithelial cells, Endothelial cells, Monocytes, Fibroblasts, and Smooth muscle cells. Furthermore, we ascertained that five subgroups of Neutrophils, each representing diverse differentiation states, exhibit close associations with immune regulatory and metabolic pathways.From our analysis of intersecting genes in the TCGA-CESC dataset, we successfully identified four prognostic genes: C5AR1, HSPA5, CXCL2, and OLR1. The stability of our prognostic risk model has been reiterated through internal and external validation, demonstrating its high consistency, differentiation, and clinical applicability. Notably, the CIRBESORT analysis divulged diminished immune cell content within the tumor immune microenvironment of the high-risk group, correlating with an unfavorable prognosis. Low expression of C5AR1 and high expression of HSPA5, CXCL2, and OLR1 were significantly associated with shorter survival and poorer prognosis.Conclusion: This study elucidated the intricate regulatory network governing the immune microenvironment in CC and comprehensively analyzed intercellular interactions.highlighting the significant roles of C5AR1, HSPA5, CXCL2, and OLR1 in predicting patient prognosis and responsiveness to immunotherapy. These findings offer novel insights and potential strategies for identifying fresh treatment targets in CC. Conclusion: This study elucidated the regulatory network of immune microenvironment in CC, and analyzed the interaction between cells. the key roles of C5AR1, HSPA5, CXCL2 and OLR1 in predicting patient prognosis and response to immunotherapy were revealed. This provides new insights and possible strategies for finding new CC treatment targets.

Publisher

Research Square Platform LLC

全球学者库

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"全球学者库"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前全球学者库共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2023 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3